Evaluation of Important Treatment Parameters in Supraphysiological Thermal Therapy of Human Liver Cancer HepG2 Cells

被引:0
|
作者
Bhavik Shah
Sankha Bhowmick
机构
[1] University of Massachusetts,Department of Mechanical Engineering
[2] Dartmouth,Bioengineering and Biotechnology Program
[3] University of Massachusetts,undefined
[4] Dartmouth,undefined
来源
关键词
Heating rates; Peak temperatures; Hold time; Total treatment time; Minimal treatment time; Injury kinetics; Arrhenius model; Clinical protocols;
D O I
暂无
中图分类号
学科分类号
摘要
This study was aimed at simulating the effect of various treatment parameters like heating rate (HR), peak temperature (PT) and hold/total treatment time on the viability of human liver cancer HepG2 cells subjected to different thermal therapy conditions. The problem was approached by investigating the injury kinetics obtained using experimentally measured viability of the cells, heated to temperatures of 50–70°C for 0–9 min at HRs of 100, 200, 300 and 525°C min−1. An empirical expression obtained between the activation energy (E) and HR was extended to obtain the E values over a broad range of HRs from 5 to 600°C min−1 that mimic the actual conditions encountered in a typical thermal therapy protocol. Further, the effect of the HR (5–600°C min−1) and PT (50–85°C) on the cell survival was studied over a range of hold times. A significant drop in survival from 90% to 0% with the simultaneous increase in HR and PT was observed as the hold time increased from 0 to 5 min. For complete cell death, the hold time increased with the increase in the HR for a given PT, while the total time showed presence of minima for 60, 65 and 70°C at HRs of 50, 100 and 200°C min−1, respectively.
引用
收藏
页码:1745 / 1757
页数:12
相关论文
共 50 条
  • [1] Evaluation of important treatment parameters in supraphysiological thermal therapy of human liver cancer HepG2 cells
    Shah, Bhavik
    Bhowmick, Sankha
    ANNALS OF BIOMEDICAL ENGINEERING, 2006, 34 (11) : 1745 - 1757
  • [2] Resveratrol enhances anticancer effects of paclitaxel in HepG2 human liver cancer cells
    Qin Jiang
    Manyi Yang
    Zhan Qu
    Jixiang Zhou
    Qi Zhang
    BMC Complementary and Alternative Medicine, 17
  • [3] Histidine and protein metabolism in human liver cells (HepG2).
    Shaw, HA
    Failla, ML
    Cave, KD
    Hopkins, R
    Park, K
    FASEB JOURNAL, 1997, 11 (03): : 2125 - 2125
  • [4] Resveratrol enhances anticancer effects of paclitaxel in HepG2 human liver cancer cells
    Jiang, Qin
    Yang, Manyi
    Qu, Zhan
    Zhou, Jixiang
    Zhang, Qi
    BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2017, 17
  • [5] Exogenous regucalcin suppresses the growth of human liver cancer HepG2 cells in vitro
    Yamaguchi, Masayoshi
    Murata, Tomiyasu
    ONCOLOGY REPORTS, 2018, 39 (06) : 2924 - 2930
  • [6] FAXDC2 inhibits the proliferation and invasion of human liver cancer HepG2 cells
    Peng, Zhilin
    Xu, Siting
    Zhang, Qing
    Yang, Xueting
    Yuan, Wuzhou
    Wang, Yuequn
    Li, Yongqing
    Zhu, Ping
    Wu, Xiushan
    Jiang, Zhigang
    Li, Fang
    Fan, Xiongwei
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2024, 27 (01)
  • [7] RTCA Monitors the Inhibitory Effect of SWCNTs on the Proliferation of human liver cancer HepG2 cells
    Zhang, Boya
    Yang, Lei
    Wang, Hua
    Liu, Ming
    Zhang, Xiuxia
    Liu, Meiling
    Shen, Jing
    Liu, Zhipeng
    Zhao, Zhuo
    Zhang, Yuan
    2019 INTERNATIONAL CONFERENCE ON ADVANCED ELECTRONIC MATERIALS, COMPUTERS AND MATERIALS ENGINEERING (AEMCME 2019), 2019, 563
  • [8] Toxicity Assessment of Octachlorostyrene in Human Liver Carcinoma (HepG2) Cells
    Ren, Guofa
    Wu, Kangming
    An, Jing
    Shang, Yu
    Zheng, Kewen
    Yu, Zhiqiang
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2022, 19 (21)
  • [9] Cellular effects of metolachlor exposure on human liver (HepG2) cells
    Hartnett, Sean
    Musah, Sadiatu
    Dhanwada, Kavita R.
    CHEMOSPHERE, 2013, 90 (03) : 1258 - 1266
  • [10] Toxicogenomic responses of human liver HepG2 cells to silver nanoparticles
    Sahu, Saura C.
    Zheng, Jiwen
    Yourick, Jeffrey J.
    Sprando, Robert L.
    Gao, Xiugong
    JOURNAL OF APPLIED TOXICOLOGY, 2015, 35 (10) : 1160 - 1168